Similar articles

• Global extent of chloroquine-resistant Plasmodium vivax.

  Wang W, Liang Y, Jie Z, Wu S, Wang H. Wang W, et al. Lancet Infect Dis. 2015 Jun;15(6):630. doi: 10.1016/S1473-3099(15)00016-X. Epub 2015 May 17. Lancet Infect Dis. 2015. PMID: 26008830 No abstract available.
• Global extent of chloroquine-resistant Plasmodium vivax - Authors' reply.

  Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Price RN, et al. Lancet Infect Dis. 2015 Jun;15(6):630-1. doi: 10.1016/S1473-3099(15)00018-3. Epub 2015 May 17. Lancet Infect Dis. 2015. PMID: 26008832 Free PMC article. No abstract available.
• Antimalarial resistance: is vivax left behind?

  Ariey F, Paul RE. Ariey F, et al. Lancet Infect Dis. 2014 Oct;14(10):908-9. doi: 10.1016/S1473-3099(14)70921-1. Epub 2014 Sep 8. Lancet Infect Dis. 2014. PMID: 25213734 No abstract available.
• [Research progress on Plasmodium vivax chloroquine resistance].

  Li JY, Li Q, Fang Q. Li JY, et al. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2014 Jun;26(3):326-31. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2014. PMID: 25345166 Review. Chinese.
• New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.

  Price RN, Douglas NM, Anstey NM. Price RN, et al. Curr Opin Infect Dis. 2009 Oct;22(5):430-5. doi: 10.1097/QCO.0b013e32832f14c1. Curr Opin Infect Dis. 2009. PMID: 19571748 Review.